SYCP2L rs10732516: What Your Genotype Means
Variant rs10732516 is a single-nucleotide polymorphism mapping to chromosome 11 in the vicinity of key reproductive and developmental regulatory loci. In reproductive genomics and catalog records, it is associated with SYCP2L, meiotic chromosome pairing, and subtle variations in female reproductive lifespan and natural menopause timing. Scientific evidence for its direct functional effect remains limited, indicating it serves primarily as a modest statistical marker rather than a definitive predictor.
What each genotype means
Typical reproductive lifespan timing
You carry two copies of the common A allele for this SYCP2L variant. Large-scale genome-wide studies link this baseline profile with standard population timing for natural menopause and female reproductive lifespan. This single marker has a very minor statistical effect on timing, and overall reproductive longevity is shaped by many genetic and lifestyle factors.
Carried by roughly 50% to 65% of individuals of European ancestry, and common across other global populations.
Slight variation in reproductive lifespan
You carry one copy of the G allele in the SYCP2L region. Population-level association studies show a modest statistical shift in the timing of natural menopause and meiotic chromosomal dynamics. Because menopause timing is a complex polygenic trait influenced by hundreds of variants, carrying a single G allele does not determine personal fertility or menopausal age.
Carried by approximately 35% to 45% of individuals in European populations.
Slight variation in reproductive lifespan
You carry two copies of the G allele for this SYCP2L marker. In genome-wide association research, carrying two copies of this variant allele is associated with a small, incremental statistical effect on female reproductive lifespan and natural menopause timing. This result represents a mild statistical predisposition rather than a clinical diagnosis, and individual fertility depends on many health and genetic components.
Carried by approximately 4% to 9% of individuals of European ancestry.
What Is rs10732516 and Where Does It Reside?
The variant rs10732516 represents a common single-nucleotide substitution involving adenine and guanine alleles (commonly denoted as an A/G transition on the forward genomic strand, or C/T depending on coordinate orientation). In the human genome, this position lies in a tightly coordinated regulatory domain that includes critical epigenetic architecture and meiotic gene neighborhoods. Within genetic reference databases such as dbSNP, rs10732516 is recognized as an intergenic or regulatory variant. Rather than altering a protein coding sequence directly (such as causing a missense or nonsense mutation), polymorphisms in this class typically modulate non-coding genomic elements. These elements often include transcription factor binding sites, long non-coding RNA scaffolds, or nearby chromatin architectural loops. Consequently, rs10732516 serves primarily as an inherited genomic marker that reflects the surrounding sequence structure and local linkage disequilibrium patterns across diverse human populations.
The Biological Role of SYCP2L and Chromosome Pairing
In reproductive genetics catalogs, rs10732516 is tagged in proximity to SYCP2L (synaptonemal complex protein 2 like). The synaptonemal complex is an evolutionarily conserved, tripartite protein lattice that forms between homologous chromosomes during prophase I of meiosis. In females, primary oocytes enter meiosis during fetal development and arrest at prophase I for decades until ovulation occurs. Proper assembly and maintenance of this synaptonemal structure are indispensable for homologous chromosome alignment, double-strand break repair, and crossover recombination. Proteins within this network, including the factor encoded by SYCP2L, play a central role in protecting the structural integrity of oocytes during this prolonged arrested state. Disruption in synaptonemal complex integrity or meiotic checkpoint regulation can lead to accelerated oocyte loss, compromised ovarian follicular pools, and variations in baseline ovarian reserve. While severe deleterious mutations in synaptonemal genes can lead to premature ovarian insufficiency, common regulatory variants like rs10732516 represent subtle background variations that may influence baseline meiotic fidelity or transcript stability across ovarian tissue aging.
Research Associations: Reproductive Lifespan and Evidence Strength
Genome-wide association studies (GWAS) exploring complex female reproductive traits—such as age at natural menopause (ANM) and overall reproductive lifespan—have repeatedly pinpointed loci involving meiotic maintenance and DNA repair genes. In these large-scale discovery cohorts, variants tagging the SYCP2L region have demonstrated statistical associations with small shifts in menopausal timing, often on the scale of a few weeks or months per inherited allele. However, the scientific evidence for rs10732516 itself is classified as limited. While meiotic chromosome biology is fundamentally linked to follicular survival, individual common variants in this locus explain only a tiny fraction of the heritable variation in menopause onset. In addition, because rs10732516 resides near complex chromatin-insulator regions (such as CTCF zinc-finger binding sequences), some functional studies examine its impact on local methylation rather than isolated protein alterations. The evidence remains primarily correlational, and rs10732516 should be regarded as a minor contributing feature in a polygenic landscape rather than a standalone causative driver.
Understanding the Variant Across Populations
The minor allele frequency (MAF) of rs10732516 varies meaningfully across global cohorts. In populations of European ancestry, catalog records and genomic reference sets report a minor allele frequency of approximately 0.20 to 0.30, making the alternate allele relatively common. In contrast, frequency distributions can vary substantially across individuals of African, East Asian, and admixed ancestry due to differing demographic histories and local recombination structures. Because genome-wide association studies on reproductive longevity have historically enrolled predominantly individuals of European descent, the predictive consistency of tag SNPs across other ancestral groups cannot be assumed. The specific genetic variants co-inherited alongside rs10732516 (known as the haplotype background) may differ significantly between populations. Therefore, any statistical trend tied to this marker cannot be broadly generalized across ancestries without formal, diverse replication.
What You Can and Cannot Do With This Information
If you have discovered your rs10732516 genotype through commercial or personal DNA sequencing, it is crucial to place these data into proper context. A specific genotype at rs10732516 does not diagnose infertility, predict early menopause, or serve as a biological timer for pregnancy planning. Reproductive aging is heavily shaped by non-genetic factors—including smoking history, medical treatments, baseline nutrition, and overall systemic health—as well as thousands of other additive genetic variants. You can use this information purely as an educational window into human meiotic biology and scientific discovery. If you have clinical questions regarding your fertility reserve, family planning, or menopausal symptoms, seek formal guidance from a board-certified gynecologist or reproductive endocrinologist. Validated clinical tests (such as serum anti-Müllerian hormone [AMH] levels and antral follicle counts) provide direct physiological assessments that individual common SNPs cannot match.
How common is this variant?
The minor allele frequency of rs10732516 is approximately 0.20 to 0.30 in populations of European ancestry. Frequencies and underlying haplotype structures can vary across other global ancestral groups, where current evidence remains less extensively characterized.
Frequently asked questions
Does having the minor allele at rs10732516 mean I will enter menopause early?
No. Natural menopause timing is a complex quantitative trait governed by thousands of genetic markers interacting with lifestyle and environmental variables. While variants near SYCP2L show small statistical correlations in large population cohorts, no single common SNP can accurately forecast the timing of your menopause.
Why is the evidence strength for this variant labeled as limited?
Evidence is considered limited because rs10732516 is primarily a tag SNP identified in broad statistical scans, rather than an unequivocally proven functional mutation. While its neighboring gene SYCP2L is fundamentally involved in meiotic biology, individual associations with reproductive spans account for minuscule individual effect sizes and may vary depending on genetic ancestry.
Can my doctor use rs10732516 to test my ovarian reserve?
No. Individual genetic variants like rs10732516 are not clinically validated or approved biomarkers for ovarian reserve. Clinicians assess reproductive lifespan and ovarian status through validated diagnostic tools, such as transvaginal ultrasound (antral follicle count) and serum hormone measurements (including AMH and FSH).
Does rs10732516 influence how I respond to hormone replacement therapy (HRT)?
There is no validated evidence establishing that rs10732516 alters drug metabolism, therapeutic efficacy, or side effects for hormone replacement therapies or fertility medications. Any decisions regarding reproductive medications or hormone therapy should always be discussed directly with your prescribing physician or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10732516?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29